Literature DB >> 3945396

L-carnitine treatment in glutaric aciduria type I.

D W Seccombe, L James, F Booth.   

Abstract

Patients with organic aciduria may have a higher than normal requirement for L-carnitine. In a patient with type I glutaric aciduria, serum total L-carnitine levels were 8.5 microM (normal, 54.4 +/- 14.2 [2 SD] microM). After treatment with L-carnitine for 1 month, serum levels of both free and total L-carnitine were normal with an acyl-to-total ratio of 0.18. The fractional clearance rates of free and acylcarnitine were increased fourfold by treatment. Acetylcarnitine accounted for a lower than normal percentage of acylcarnitine recovered in serum and urine. Data suggest that this patient may have been carnitine-deficient.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945396     DOI: 10.1212/wnl.36.2.264

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).

Authors:  S Kölker; E Christensen; J V Leonard; C R Greenberg; A B Burlina; A P Burlina; M Dixon; M Duran; S I Goodman; D M Koeller; E Müller; E R Naughten; E Neumaier-Probst; J G Okun; M Kyllerman; R A Surtees; B Wilcken; G F Hoffmann; P Burgard
Journal:  J Inherit Metab Dis       Date:  2007-01-03       Impact factor: 4.982

2.  A Case Report of Chronic Progressive Pancerebellar Syndrome with Leukoencephalopathy:L-2 Hydroxyglutaric Aciduria.

Authors:  Heli Shah; Mitesh Chandarana; Jayesh Sheth; Sudhir Shah
Journal:  Mov Disord Clin Pract       Date:  2020-05-20

3.  The importance of recognizing secondary carnitine deficiency in organic acidaemias: case report in glutaric acidaemia type II.

Authors:  H Mandel; D Africk; M Blitzer; E Shapira
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 4.  Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.

Authors:  Nikolas Boy; Chris Mühlhausen; Esther M Maier; Jana Heringer; Birgit Assmann; Peter Burgard; Marjorie Dixon; Sandra Fleissner; Cheryl R Greenberg; Inga Harting; Georg F Hoffmann; Daniela Karall; David M Koeller; Michael B Krawinkel; Jürgen G Okun; Thomas Opladen; Roland Posset; Katja Sahm; Johannes Zschocke; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-11-16       Impact factor: 4.982

5.  Glutaric aciduria type I. Brain CT features and a diagnostic pitfall.

Authors:  H Mandel; J Braun; O el-Peleg; E Christensen; M Berant
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 6.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 7.  Diagnosis and management of glutaric aciduria type I--revised recommendations.

Authors:  Stefan Kölker; Ernst Christensen; James V Leonard; Cheryl R Greenberg; Avihu Boneh; Alberto B Burlina; Alessandro P Burlina; Marjorie Dixon; Marinus Duran; Angels García Cazorla; Stephen I Goodman; David M Koeller; Mårten Kyllerman; Chris Mühlhausen; Edith Müller; Jürgen G Okun; Bridget Wilcken; Georg F Hoffmann; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2011-03-23       Impact factor: 4.982

8.  Glutaric aciduria yype 1: First reported cases in three Saudi patients.

Authors:  R Coates; M Rashed; Z Rahbeeni; S Al-Garawi; A N Al-Odaib; N Sakati; G Gascon; H Worthen; P T Ozand
Journal:  Ann Saudi Med       Date:  1994-07       Impact factor: 1.526

9.  Inconsistencies in the Nutrition Management of Glutaric Aciduria Type 1: An International Survey.

Authors:  Laurie Bernstein; Curtis R Coughlin; Morgan Drumm; Steven Yannicelli; Fran Rohr
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.